Equity Overview
Price & Market Data
Price: $2.60
Daily Change: -$0.04 / 1.54%
Daily Range: $2.55 - $2.74
Market Cap: $35,225,320
Daily Volume: 66,249
Performance Metrics
1 Week: 7.88%
1 Month: -9.09%
3 Months: -11.26%
6 Months: -4.76%
1 Year: -52.38%
YTD: -10.34%
Company Details
Employees: 46
Sector: Health technology
Industry: Pharmaceuticals: major
Country:
Details
OnKure Therapeutics, Inc., a clinical-stage biopharmaceutical company, focuses on the discovery and development of precision medicines that target biologically validated drivers of cancers. Its lead product candidate includes OKI-219, a selective inhibitor of phosphoinositide 3 kinase alpha harboring the H1047R mutation that is in Phase 1 clinical trial for the treatment of solid tumors, including breast cancer. The company is headquartered in Boulder, Colorado.